Amgen: brands it owns and its ownership tree
Amgen (NASDAQ: AMGN) is a publicly listed company headquartered in Thousand Oaks, United States that owns 17 consumer brands.[1]
Amgen is a US biotechnology company. Its 2025 Form 10-K lists marketed products across general medicine, oncology, inflammation and rare disease, including biosimilars.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
divestitures recorded
Company facts
- Legal name
- Amgen Inc.
- Type
- publicly listed company · see all publicly listed company owners
- Headquarters
- 🇺🇸 Thousand Oaks, United States
- Founded
- 1980
- Tickers
- NASDAQ: AMGN
- SEC CIK
- 0000318154
- Last verified
- · 1 sources
Amgen in numbers
- Amgen owns 17 consumer brands tracked here across 1 top-level categories; the largest is healthcare & pharma with 17 brands.[1]
Everything Amgen owns
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Full-screen interactive tree → · Download as infographic
Brand portfolio by category
Recent changes to this record
Official recalls involving Amgen products
4 recall notices from government regulators matched to Amgen. Each applies to the specific products, sizes and lot codes named in the notice, not to every product sold under the name.
- Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC 55513-800-99), and b) 60 tablet bottles (NDC 55513-800-60), Rx Only, Amgen Inc.,… — FDA, · Class II
Reason given: Presence of Foreign Substance.
Recalling firm: Amgen, Inc.
- Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy. NDC 55513-810-60 — FDA, · Class II
Reason given: Presence of Foreign Substance.
Recalling firm: Amgen, Inc.
- Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No… — FDA, · Class II
Reason given: Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Recalling firm: Amgen, Inc.
- Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile… — FDA, · Class II
Reason given: Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Recalling firm: Amgen, Inc.
Matched automatically from FDA, USDA FSIS, UK Food Standards Agency and CPSC records only when the recalling firm corresponds to this ownership record and, for a brand, the brand name appears in the product description. Check the linked notice for exact products and lots. Method.
Frequently asked questions
What brands does Amgen own?
Amgen owns 17 consumer brands tracked here, including Imdelltra, Blincyto, Kyprolis, Lumakras, Neulasta and Parsabiv.
Is Amgen an American company?
Yes. Amgen is headquartered in Thousand Oaks, United States and was founded in 1980.
Who owns Amgen?
Amgen is a publicly listed company owned by its shareholders; it trades as AMGN on the NASDAQ.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Amgen Inc. Annual Report on Form 10-K filed 2026-02-13 — SEC EDGAR, SEC Form 10-K, published 13 February 2026; retrieved 15 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.